You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Which of the following is a new oral drug approved for Rheumatoid ahritis? and explain in detail?
UPADACITINIB : - It is an oral JAK 1 inhibitors like tofacitinib - Used for Rheumatoid ahritis to slow down the disease progression. FEDRATINIB : - It is a oral JAK 2 inhibitor . - Used for MYELOFIBROSIS ENTRECTINIB : - It is oral Tyrosine kinase inhibitor. - Used for ROS - 1 positive NON SMALL CELL LUNG CANCER and NK positive solid tumors. TALAZOPARIB : - PARP inhibitor like olaparib - Used for breast cancer.